School of Medicine Publications and Presentations

Document Type

Article

Publication Date

9-2022

Abstract

Introduction: Several vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 (COVID-19) in December 2019, at unprecedented speed. However, these rapidly developed vaccines raised many questions related to the efficacy and safety of vaccines in different communities across the globe. Various hypotheses regarding COVID-19 and its vaccines were generated, and many of them have also been answered with scientific evidence. Still, there are many myths/misinformation related to COVID-19 and its vaccines, which create hesitancy for COVID-19 vaccination, and must be addressed critically to achieve success in the battle against the pandemic.

Area covered: The development of anti-SARS-CoV-2 vaccines against COVID-19, their safety and efficacy, and myths/misinformation relating to COVID-19 and vaccines are presented.

Expert opinion: In this pandemic we have seen a global collaborative effort of researchers, governments, and industry, supported by billions of dollars in funding, have allowed the development of vaccines far more quickly than in the past. Vaccines go through rigorous testing, analysis, and evaluations in clinical settings prior to their approval, even if they are approved for emergency use. Despite the myths, vaccination represents an important strategy to get back to normality.

Comments

This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Review of Vaccines on 18 Aug 2022 available at: https://doi.org/10.1080/14760584.2022.2114900

Publication Title

Expert Review of Vaccines

DOI

10.1080/14760584.2022.2114900

Academic Level

faculty

Mentor/PI Department

Immunology and Microbiology

Available for download on Friday, August 18, 2023

Included in

Public Health Commons

Share

COinS